Doctors Note Logo

Published on: 7/21/2026

How prevalent is muscle loss among GLP-1 users?

Muscle loss is a known side effect of GLP-1 medications such as semaglutide, particularly when weight loss happens rapidly or without regular strength training and adequate protein intake. Because these drugs reduce appetite and overall calorie consumption, the body may break down lean muscle tissue alongside fat, which can slow metabolism, weaken strength, and impact long-term health outcomes.

If you're taking a GLP-1 medication and noticing fatigue, weakness, or changes in your body composition, it's important to identify the cause early. A free, instant, online symptom check can help you understand whether your symptoms are linked to muscle loss, nutritional gaps, or another underlying issue—giving you clear, personalized guidance on what to do next before small concerns turn into bigger problems.

Reviewed for medical accuracy: 07/20/2026

answer background

Explanation

GLP-1 medications, such as semaglutide, are often used for weight loss and diabetes management. According to the studies, some users experience a decrease in muscle mass, particularly when they lose weight rapidly. If you're concerned about changes in your body composition or experiencing unexpected symptoms while on GLP-1 therapy, consider taking a free AI symptom checker to better understand what you're experiencing.

Key Points:

  1. Lean Mass Changes: A study found that while GLP-1 helps with weight loss, it can also lead to muscle loss, especially if the weight loss is fast.
  2. Semaglutide Effects: Another review highlighted that semaglutide users might lose some muscle mass, but this varies among individuals.
  3. Diet and Exercise: Maintaining muscle mass during weight loss is possible with a balanced diet and regular exercise, as suggested by research on nutrition and physical activity.

To minimize muscle loss, it's important to combine GLP-1 therapy with healthy eating and physical activity. This approach helps preserve muscle while benefiting from the weight loss effects of the medication.

(References)

  • Neeland IJ, Linge J, & Birkenfeld AL. (2024). Changes in lean body mass with glucagon-like peptide-1- .... Diabetes, obesity & metabolism, 38937282.

  • Bikou A, Dermiki-Gkana F, Penteris M, Constantinides TK, & Kontogiorgis C. (2024). A systematic review of the effect of semaglutide on lean mass. Expert opinion on pharmacotherapy, 38629387.

  • Grosicki GJ, Dhurandhar NV, Unick JL, Arent SM, Thomas JG, Lofton H, et al. (2024). The Importance of Diet and Physical Activity to Support .... Current developments in nutrition, 39624804.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.